Prismic Pharmaceuticals Inc Scottsdale, AZ - 85258

Prismic Pharmaceuticals Inc is categorized under in Scottsdale, AZ and active since 2011.

Prismic Pharmaceuticals Inc was established in 2011, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a business, which does work in the BOTH market, and is classified as a , under code number 3254120 by the NAICS.

If you are seeking more information, feel free to contact Peter Moriarty, Chief Executive Officer at the company’s single location by writing to 8283 North Hayden Road # 270, Scottsdale, Arizona AZ 85258 or by phoning (480) 422-1813. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Prismic Pharmaceuticals Inc
Contact Person: Peter Moriarty, Chief Executive Officer
Address: 8283 North Hayden Road # 270, Scottsdale, Arizona 85258
Phone Number: (480) 422-1813
Website Address: prismicpharma.com
Annual Revenue (USD): $5.000.000 to $9.999.999
Founded: 2011
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B & B2C
Business Category:
SIC Code: 2834
NAICS Code: 3254120
Share This Business:

Prismic Pharmaceuticals Inc was started in 2011 to provide professional under the SIC code 2834 and NAICS code 3254120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.

Feel free to contact Peter Moriarty, Chief Executive Officer for inquiries that concern Prismic Pharmaceuticals Inc by calling the company number (480) 422-1813, as your correspondence is most welcome. Additionally, the physical location of the single location of Prismic Pharmaceuticals Inc can be found at the coordinates 33.556572,-111.898622 as well as the street address 8283 North Hayden Road # 270 in Scottsdale, Arizona 85258.

For its online presence, you may visit Prismic Pharmaceuticals Inc’s website at prismicpharma.com and engage with its social media outlets through on Twitter and on Facebook.